Influence of morning and evening melatonin administration on the mucosa and crypts of a small intestine in rats with obesity

I. Vareniuk, N. Shevchuk, N. Roslova, M. Dzerzhynsky
Taras Shevchenko National University of Kyiv, Kyiv; Taras Shevchenko National University of Kyiv, Kyiv; Taras Shevchenko National University of Kyiv, Kyiv; Taras Shevchenko National University of Kyiv, Kyiv

Abstract


The aim of this work was to determine structural and functional changes in a small intestine of rats after morning and evening administration of melatonin in obese animals during the spring-autumn photoperiod (12L:12D). The obesity was caused with a high-calorie diet for 6 weeks. After that, morning or evening melatonin administrations were given to normal and obese animals at a dose of 30 mg/kg for 7 weeks. After that, paraffin sections of the small intestine were made, on which a state of the mucosa, enterocytes and goblet cells in crypts was morphometrically and visually examined under a microscope. It has been shown, that obesity causes swelling and an increase of thickness of a mucosa, reduction of crypts, a decrease of activity of enterocytes and goblet cells of the small intestine. Introduction of melatonin to animals without obesity causes an increase in thickness of mucosa and a decrease in area of goblet cells. Additionally, after morning melatonin administration a depth of crypts and a height of enterocytes increases. Morning administration of melatonin to obese animals partially recovers crypts and their goblet cells, but doesn't prevent mucosal edema and worsens a state of enterocytes. The evening administration of melatonin partially normalizes all structural changes, caused by obesity. It was concluded, that melatonin may partially correct morpho-functional changes in the small intestine, caused by obesity in the spring and autumn seasons. The evening administration of melatonin to animals with obesity is more effective, than morning administrations. Also, the evening administration of melatonin causes fewer changes in the small intestine of animals without obesity, compared with morning administration.

Keywords


melatonin, obesity, small intestine

Full Text:

PDF>PDF

References


Araujo J., Tomas J., Brenner C., Sansonetti J. Impact of high-fat diet on the intestinal microbiota and small intestinal physiology before and after the onset of obesity. Biochimie. 2017;141:97-106.

Cardinali D., Cano P., Jimenez-Ortega V., Esquifino A. Neuroendocrinol melatonin and the metabolic syndrome: physiopathologic and therapeutical implications. Neuroendocrinology. 2011;93(3):131-142.

Cardinali P., Hardeland R. Inflammaging, metabolic syndrome and melatonin: a call for treatment studies. Neuroendocrinology. 2017;104(4):382-397.

Delagrange P., Atkinson J., Boutin A., Casteilla L., Lesieur D., Misslin R., Pellissier S., Penicaud L., Renard P. Therapeutic perspectives for melatonin agonists and antagonists. Journal of neuroendocrinology. 2003;15(4):442-448.

Jimenez-Aranda A., Fernandez-Vazquez G., Campos D., Tassi M., Velasco-Perez L., Tan X., Reiter J., Agil A. Melatonin induces browning of inguinal white adipose tissue in Zucker diabetic fatty rats. J Pineal Res. 2013;55(4):416-423.

Konturek C., Brzozowski T., Konturek J. Gut clock: implication of circadian rhythms in the gastrointestinal tract. J Physiol Pharmacol. 2011;62(2):139-150.

Liu J., Clough J., Hutchinson J., Adamah-Biassi B., PopovskaGorevski M., Dubocovich L. MT1 and MT2 melatonin receptors: a therapeutic perspective. Annual review of pharmacology and toxicology. 2016;56:361-383.

Luzina V., Tomina A., Zhilina A. Obesity and diseases of digestive organs. Klin Med (Mosk). 2013;91(6):63-67.

Nduhirabandi F., Toit E., Lochner A. Melatonin and the metabolic syndrome: a tool for effective therapy in obesity-associated abnormalities. Acta Physiol (Oxf). 2012;205(2):209-223.

Prado N., Ferd L., Manucha W. Anti-inflammatory effects of melatonin in obesity and hypertension. Curr Hypertens Rep. 2018;20(3):1-15.

Reiter R., Manchester L., Fuentes-Broto L., Tan D. Cardiac hypertrophy and remodeling: pathophysiological consequences and protective effects of melatonin. J Hypertens. 2010;28(2):7-12.

Reiter R., Tan D., Korkmaz A., Mac S. Obesity and metabolic syndrome: association with chronodisruption, sleep deprivation, and melatonin suppression. Ann Med. 2012;44(1):564-577.

Ryu V., Zarebidaki E., Albers E., Xue B., Bartness J. Short photoperiod reverses obesity in Siberian hamsters via sympathetically induced lipolysis and Browning in adipose tissue. Physiol Behav. 2018;190:11-20.

Szewczyk‐Golec K., Wozniak A., Reiter J. Inter‐relationships of the chronobiotic, melatonin, with leptin and adiponectin: implications for obesity. Journal of pineal research. 2015;59(3):277-291.

Torres-Farfan C., Valenzuela F., Mondaca M. Evidence of a role for melatonin in fetal sheep physiology: direct actions of melatonin on fetal cerebral artery, brown adipose tissue and adrenal gland. J Physiol. 2008;586(2):4017-4027.

Received: 06.05.2019

Revised: 07.06.2019

Accepted & Published: 07.06.2019




DOI: http://dx.doi.org/10.17721/1728_2748.2019.78.50-53

Refbacks

  • There are currently no refbacks.


Лицензия Creative Commons
This journal is available according to the Creative Commons License «Attribution» («Атрибуція») 4.0 Global (CC-BY).